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Cynthia Trinh
Biochemistry: Science in the News #2
6 October 2018
Rare Antibodies Show Scientists How to Neutralize the Many Types of Ebola
https://www.scripps.edu/news-and-events/press-room/2018/20180912-ebola-antibodytherapy.html
The Ebola virus, a rare, but deadly disease, was first discovered in 1975 near the Ebola
River, which is now the Democratic Republic of Congo, and had recent outbreaks the past few
years. The Ebola virus has no approved vaccines or treatments, however, there are researches
that are focusing on discovering the virus’s natural host, developing vaccines, and discovering
therapies to improve treatment of the disease. Developing a vaccine or finding a treatment for
this disease is challenging, since the Ebola virus is not just one pathogen, but five; the disease is
caused by an infection group of viruses within the genus Ebolavirus (Ebola, Sudan, Taï Forest,
Bundibugyo and Reston viruses).
In this news article, two new studies done by scientists at Scripps Research have
discovered a weak spot in the Ebola virus and other closely related pathogens that can be
targeted by a human antibody known as ADI-15878, which was found in the blood of an Ebola
virus survivor. It is also the only human antibody found that neutralizes all five members of the
Ebolavirus genus. For their research, the scientists used X-ray crystallography to see the
interactions between the ADI-15878 antibody with Ebola’s glycoprotein. Ebola’s glycoprotein
(protein that allows a virus to infect a cell), is covered in sugars that mask the virus from being
detected by the body’s immune system. They hypothesized that locking the Ebola’s fusion
machinery will make it impossible for the virus to infect the human cells and the fusion loop of
the virus cannot be easily mutated, which meant that having an antibody that can target that
structure would provide broad protection from the virus. They soon discovered that the ADI15878 antibody binds to a site on the viral fusion loop, which prevents the fusion of the virus to
the human cell and initiates infection. The scientists had also tested this idea with a mouse
antibody known as 6D6, to a mouse who was immunized with Ebola virus and the Sudan virus.
Both the 6D6 antibody and the ADI-15878 antibody bound to the same region and neutralized
the known types of Ebola.
I had chosen this article, since the topic of treatment to diseases has always been an
interest of mine. This article was also related to what we had learned in class about how
antibodies were starting to be used as treatment options in certain diseases.
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